Abbott Recalls Synthroid Batches

Three lots of Synthroid—a synthetic thyroid hormone—were recalled by Abbott Laboratories owing to defects in the bottles that may compromise the stability of the tablets. 

The Food and Drug Administration (FDA) issued a Class II recall of the product on its web site last week.  A Class II recall is issued when the product can cause a temporary health problem or slight risk of a more serious issue.

The company said that it wasn’t aware of any adverse events so far related to the recalled lots.

At least 136,500 Synthroid bottles in the recalled lots had thin plastic at the bottom of the bottles that could allow moisture to enter the bottle and destabilize the tablets, according to Dow Jones Newswires.

Synthroid is prescribed to people affected with hypothyroidism—a condition when the thyroid glands don’t produce sufficient level of hormones.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law today for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you.

Tags: